CROI 2020 Program and Conference Information

Oral Sessions

942

COMPARISON OF INDEX TESTING APPROACHES TO IMPROVE HIV-TESTING EFFICIENCY IN RWANDA Eric Remera , Elyse Tuyishime, Suthar Amithab, Mugwaneza Placidie

Symposium S-01 NOVEL CURE INTERVENTIONS Ballroom B 4:00 PM - 6:00 PM Target Audience: This session is directed to clinicians and scientists who are interested in understanding strategies for the cure of HIV infection. Level of Knowledge: It is assumed that the participants are familiar with stages of the viral life cycle and have a basic understanding of molecular biology. Objectives: At the completion of the session, participants will be able to: • Explain novel cure interventions in terms of basic mechanisms • Describe results from pre-clinical animal model studies on HIV cure CME

Conveners Michaela Müller-Trutwin , Institut Pasteur, Paris, France Katherine Bar , University of Pennsylvania, Philadelphia, PA, USA 50 INVIVOMODELS FOR THE EVALUATION OF NOVEL HIV CURE INTERVENTIONS J. Victor Garcia-Martinez , University of North Carolina at Chapel Hill, Chapel Hill, NC, USA 51 LRA 2.0: IMMUNE-BASED LATENCY REVERSAL Ann Chahroudi , Emory University, Atlanta, GA, USA 52 T-CELL AND HEMATOPOIETIC STEMCELL GENE THERAPIES FOR HIV CURE Christopher Peterson , Fred Hutchinson Cancer Research Center, Seattle, WA, USA 53 TOWARD DURABLE CONTROL OF HIV-1WITH eCD4-Ig Michael Farzan , The Scripps Research Institute, La Jolla, CA, USA Symposium S-02 HISTORY REPEATING ITSELF: SEXUALLY 5:30 4:00 4:30 5:00

Oral Sessions • Monday

CME

TRANSMITTED INFECTIONS INWOMEN AND INFANTS 4:00 PM - 6:00 PM Target Audience: This session is directed to clinicians and scientists who are interested in understanding the interactions between HIV infection and sexually transmitted infections (STIs) in pregnant women and children. Level of Knowledge: It is assumed that the participants are familiar with basic issues of the treatment and prevention of HIV and STIs as well as mother-to-child transmission. Objectives: At the completion of the session, participants will be able to: • Describe the global epidemiology of STIs that put the fetus at risk • Compare screening in low- and high-income settings and links to HIV infection • Identify treatment dilemmas in women with STIs, including drug resistance • Identify the interactions between HIV and STIs in pregnancy and in infants • Assess the prevention of STIs during pregnancy and breastfeeding • Describe vaccine programs and link to HIV eliminationn Ballroom A

CROI 2020 41